HCPCS Level II
G9651
Psoriasis assessment tool documented not meeting any one of the specified benchmarks (e.g., (pga; 5-point or 6-point scale), body surface area (bsa), psoriasis area and severity index (pasi) and/or dermatology life quality index) (dlqi)) or psoriasis assessment tool not documented
- NDC crosswalk
- None in the loaded CMS ASP file
Codes near G9651
These sit next to G9651 in the CMS Level II file. All G codes
- G9646Patients with 90 day mrs score of 0 to 2
- G9647Patients in whom mrs score could not be obtained at 90 day follow-up
- G9648Patients with 90 day mrs score greater than 2
- G9649Psoriasis assessment tool documented meeting any one of the specified benchmarks (e.g., (pga; 5-point or 6-point scale), body surface area (bsa), psoriasis area and severity index (pasi) and/or dermatology life quality index) (dlqi))
- G9650Documentation that the patient declined therapy change or has documented contraindications (e.g., experienced adverse effects or lack of efficacy with all other therapy options) in order to achieve better disease control as measured by pga, bsa, pasi, or dlqi
- G9652Patient has been treated with a systemic or biologic medication for psoriasis for at least six months
- G9653Patient has not been treated with a systemic or biologic medication for psoriasis for at least six months
- G9654Monitored anesthesia care (mac)
- G9655A transfer of care protocol or handoff tool/checklist that includes the required key handoff elements is used
- G9656Patient transferred directly from anesthetizing location to pacu or other non-icu location